Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial

Robin K. Avery, Sophie Alain, Barbara D. Alexander, Emily A. Blumberg, Roy F. Chemaly, Catherine Cordonnier, Rafael F. Duarte, Diana F. Florescu, Nassim Kamar, Deepali Kumar, Johan Maertens, Francisco M. Marty, Genovefa A. Papanicolaou, Fernanda P. Silveira, Oliver Witzke, Jingyang Wu, Aimee K. Sundberg, Martha Fournier

Research output: Contribution to journal › Article › peer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences